Skip to main content
SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
3.510
+0.030 (0.86%)
Oct 11, 2024, 4:00 PM EDT - Market closed

SOPHiA GENETICS Revenue

SOPHiA GENETICS had revenue of $15.81M in the quarter ending June 30, 2024, with 5.01% growth. This brings the company's revenue in the last twelve months to $64.94M, up 20.14% year-over-year. In the year 2023, SOPHiA GENETICS had annual revenue of $62.37M with 31.14% growth.

Revenue (ttm)
$64.94M
Revenue Growth
+20.14%
P/S Ratio
3.53
Revenue / Employee
$151,019
Employees
430
Market Cap
232.39M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202362.37M14.81M31.14%
Dec 31, 202247.56M7.11M17.58%
Dec 31, 202140.45M12.05M42.43%
Dec 31, 202028.40M3.04M11.98%
Dec 31, 201925.36M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Adaptimmune Therapeutics 141.46M
Utah Medical Products 46.58M
Nanobiotix 45.22M
Inhibrx Biosciences 1.69M
Sera Prognostics 107.00K
Revenue Rankings

SOPH News

More News